FDA to speed up approvals of generic biologic medicines
Digest more
The FDA said it proposed significant changes to simplify biosimilarity studies and reduce what it described as unnecessary ...
There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...
The US Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar ...
The United States has said it will speed up approval for some generic drugs. The development comes weeks after it was ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...
As drug prices continue to rise and the affordability of medicines for patients remains out of reach, finding new and creative solutions that address affordability, while also rewarding innovation, ...
Generic drugs feature the exact same active ingredient, strength and dosing regimen as their brand-name predecessors, but, if it weren’t for their typically lower prices, they still wouldn’t be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback